Dergiler / Middle East Journal of Science / 2016 / Cilt: 2 - Sayı: 1

DNA DAMAGE MECHANISMS OF ANTI-CANCER DRUGS

Sayfa
33–49
Yayın Tarihi
2016-06-29
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this review, DNA damage mechanisms of anti-cancer drugs are 33 discussed.Finally, natural products with extremely potent biological activities sometimes reveal unforeseen biological pathways and these compounds can become useful tools for elucidating the details of complex life processes.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Organic molecules with DNA-damage ability are of great potential in the development of medicine, toxicology, biochemistry, organic chemistry, biotechnology and gene therapy.
📊
Temel Bulgular & Veri:DNA damaging agents have historically played a central role in cancer therapy.
💡
Sonuç & Katkı:In this review, DNA damage mechanisms of anti-cancer drugs are 33 discussed.Finally, natural products with extremely potent biological activities sometimes reveal unforeseen biological pathways and these compounds can become useful tools for elucidating the details of complex life processes.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Natural Products · DNA Damage · Anti-Cancer Agents

Abstract

Organic molecules with DNA-damage ability are of great potential in the development of medicine, toxicology, biochemistry, organic chemistry, biotechnology and gene therapy. DNA damaging agents have historically played a central role in cancer therapy. Even as new approaches to cancer therapy become available, it seems likely that there will be a continued need for the study and development of novel DNA damaging cytotoxins. These agents will see continued use due to their well-establised role in treating various types of cancer and because many of the new approaches to cancer treatment such as immunoteraphy and modulation of the cell cycle are most effective when used in combination with traditional cytotoxins. It is commonly believed that natural products which display potent biological activity are results of natural selection. DNA-damaging natural products frequently possess potent cytotoxic, cytostatic or mutagenic properties and, in nature, may serve as either offensive or defensive weapon in the struggle for survival. Natural products constitute a vast library of organic compounds that can serve as a useful force. A practical reason for the longstanding interest in DNA-damaging natural products is the fact that the cytotoxic or cytostatic effects of these agents sometimes endow them with useful medicinal properties, especially as potential anticancer therapeutics. Several DNA-damaging natural products are currently in use for the treatment of various cancers and others have served as lead compounds in the development of therapeutic agents. Many anti-cancer agents work by alkylating DNA while others destroy DNA by radical chemistry, starting either (i) by abstracting a hydrogen atom from a deoxyribose sugar or (ii) by adding to the alkene pi bond in a base.DNA-damaging agents can be placed into four chemical categories: Intercalators, alkylating agents, DNA strand breakers and groove binders. In this review, DNA damage mechanisms of anti-cancer drugs are 33 discussed.Finally, natural products with extremely potent biological activities sometimes reveal unforeseen biological pathways and these compounds can become useful tools for elucidating the details of complex life processes.

🔖

Bu Makaleye Atıf Yap

TOPTANCI, B. Ç., KIZIL, G., KIZIL, M. (2016). DNA DAMAGE MECHANISMS OF ANTI-CANCER DRUGS. Middle East Journal of Science, Cilt: 2 - Sayı: 1, 33–49. https://ajindex.com/articles/691588

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Wlater, P. (2002). Molecular Biology of the Cell, fourth ed. Garland Science, Pp: 120-121. New York, Amsterdam
  2. Baraldi, P.G., Preti, D., Fruttarolo, F., Tabrizi, M.A., Romagnoli, R. (2007). Hybrid molecules between distamycin A and active moieties of antitumor agents. Bioorganic and Medicinal Chemistry, 15: 17-35
  3. Bennett, R. A. O., Swerdlow, P. S., Povirk, L. F. (1993). Spontaneous cleavage of bleomycin-induced abasic sites in chromatin and their mutagenicity in mammalian shuttle vectors. Biochemistry. 32: 3188-95
  4. Beria, I., Baraldi, P.G., Cozzi, P., Caldarelli, M., Geroni, C., Marchini, S., Mongelli, N., Romagnoli, R. (2004). Cytotoxic a-halogenoacrylic derivatives of distamycin A and congeners. Journal of Medicinal Chemistry, 47: 2611-2623
  5. Breen, A. P., Murphy, J. A. (1995). Reactions of oxyl radicals with DNA. Free Radical Biology Medicine. 18(6): 1033-77
  6. Bignell, G.R., Santarius, T., Pole, J.C.M., Butler, A.P., Perry, J., Pleasance, E., Greenman, C., Menzies, A., Taylor, S., Edkins, S., Campbell, P., Quail, M., Plumb, B., Matthews, L., McLay, K., Edwards, P.A.W., Rogers, J., Wooster, R., Futreal, P.A., Stratton, M.R. (2007). Architectures of somatic genomic rearrangement in human cancer amplicons at sequence level resolution. Genome Research, 17: 1296-1303
  7. Caponigro, F., Lorusso, D., Fornari, G., Barone, C., Merlano, M., Airoldi, M., Schena, M., MacArthur, R., Weitman, S., Jannuzzo, M., Crippa, S., Fiorentini, F., Petroccione, A., Comis, S., Phase I. (2010). Dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology, 66: 389-394
  8. Chargaff, E., Vischer, E., Doniger, R., Green, C., Misani, F. (1949). The composition of the desoxypentose nucleic acids of thymus and spleen. The Journal of Biological Chemistry, 177: 405-416
  9. Chambers, A.F., Groom, A.C., MacDonald, I.C. (2002). Metastasis: dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer, 2: 563-572
  10. Chatterji, T., M. Kızıl, K. Keerthi, G. Chowdhury, T. Pospilis ve K. S. Gates, (2003). Small Molecules That Mimic the Thiol-Triggered Alklating Properties Seen in the Natural Product Leinamycin. Journal of the American Chemical Society.125: 4996-4997
  11. Çeken, B. (205). Sentetik maddeler ile DNA kesimi. Doktora Tezi, Fen Bilimleri Enstitüsü, Dicle Üniversitesi,